{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "adds_modification",
    "modifications" : [ {
      "modification_type" : "methylation"
    } ],
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P38398",
      "entity_text" : "BRCA1",
      "entity_type" : "protein"
    },
    "is_direct" : false,
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0595" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "BRCA1 and RAD51C promoter methylation in 35% of non EC NSGCTs makes a significant proportion of these tumors candidates for treatment with PARP inhibitors.",
  "reading_complete" : "2020-08-08T15:31:05Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T15:29:07Z",
  "trigger" : "methylation",
  "evidence" : [ "BRCA1 and RAD51C promoter methylation" ],
  "pmc_id" : "6075738",
  "score" : 0
}